“novartis-institutes-for-biomedical-research” Archives

in
Entry Author Date Location
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More 05/17/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Cadent Pulls In $40M for Phase 2 Tests of Movement Disorder Drug 11/15/18 Boston
Big Pharma Seeks More Partnerships, Evidence in Digital Therapeutics 09/26/18 Boston
Zafgen Exec Thomas Hughes Resigns to Take CEO Job at Navitor 08/02/18 Boston
Bio Roundup: Hope for Lungs, Bradner’s Complaint, FDA Nods & More 04/20/18 National
Surface Oncology’s Upsized IPO Reels In $108M for Lead Cancer Drug 04/18/18 Boston
Surface Oncology Plans IPO to Advance Clinical Tests of Cancer Drug 03/26/18 Boston
Breaking Barriers & Building Bridges: Xconomy’s Diversity Award Finalists 08/23/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
Syros Files For IPO to Push “Gene Control” Drugs Through First Trials 06/06/16 Boston
With Tensha Purchase, Roche Interest in Bradner Startups Continues 01/11/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
Five Takeaways From “Boston’s Life Science Disruptors” 10/02/15 Boston
Hear the Synlogic Story at Boston’s Life Science Disruptors Sept. 30 09/14/15 Boston
“Boston’s Life Science Disruptors” to Share Their Stories on Sept. 30 07/23/15 Boston
Doudna’s Caribou Bio Raises $11M To Expand Uses For Gene Editing Tech 04/02/15 San Francisco
CART + CRISPR = 1st-Of-Its-Kind Biotech Deal From Novartis, Intellia 01/07/15 Boston
With Atlas Cash and Berkeley Tools, Intellia Joins the CRISPR Fray 11/18/14 Boston
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
One Week to Boston’s Life Science Disruptors—Check Out the Agenda 10/01/14 Boston
Hear Epizyme, Sage, Zafgen Share Their Stories on Oct. 8 09/11/14 Boston
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
East Coast Biotech Roundup: NJ Blues, Genzyme, Amicus, Biogen & More 08/25/14 Boston
Join Us For “Boston’s Life Science Disruptors” on Oct. 8 08/21/14 Boston
Bluebird, Moderna, Genocea to Share Their Stories on Oct. 2 09/12/13 Boston
Page 1 of 2 next page »